Christopher Nazaroff

Christopher Nazaroff, PhD, has extensive experience in immunology and biochemistry, with a focus on eosinophil research. As a Research Scientist at Mayo Clinic School of Medicine from January 2015 to May 2020, Christopher identified and characterized eosinophil immunophenotypes, leading to the discovery of regulatory pathways and biomarkers relevant to diagnostics and drug development. Following this, Christopher served at AstraZeneca from April 2021 to November 2023 in various roles, including Senior Scientist and Associate Director, where responsibilities included leading translational science efforts. Furthermore, as a Research Associate at Arizona State University from August 2011 to July 2013, Christopher optimized enzyme purification techniques and gained valuable leadership skills. Christopher holds a Bachelor’s Degree in Biochemistry (Medicinal Chemistry) and a Ph.D. in Biochemistry/Immunology, both from Arizona State University.